 |
인쇄하기
취소
|
Bukwang to conduct clinical trials for active isomers of thioctic acid
Bukwang Pharm unveiled its plan to conduct its own clinical trials for chemically aisomers of thioctic acid as a promising new drug.
The company will initiate clinical trials after getting an approval from the Korea Food and Drug Administration.
The safety and efficacy of the new drug was already demonstrated in experimental animals.
Thioctic acid, also known as alpha-lipoic acid, is ...
The company will initiate clinical trials after getting an approval from the Korea Food and Drug Administration.
The safety and efficacy of the new drug was already demonstrated in experimental animals.
Thioctic acid, also known as alpha-lipoic acid, is ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.